Intraneuronal dopamine-quinone synthesis: a review

Sulzer, David, Zecca, Luigi·1999·Neurotoxicity Research
DOI 10.1007/bf03033289

Cited by (282)

Items 201–282 of 282

  1. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson’s disease
    Seung Hyun Lee, Young Taek Han, Dong Seok · 2021 · Neuroscience Letters
  2. Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinsons Disease?
    Elmar Kirches · 2009 · Current Genomics
  3. Altered nitric oxide production in mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin or methamphetamine
    A Halász, M. Pálfi, Tamás Tábi, Kálmán Magyar, Éva Szökő · 2003 · Neurochemistry International
  4. Modeling Parkinson’s disease in LRRK2 rodents
    Chiara Domenicale, Stefano Magnabosco, Michele Morari · 2023 · Neuronal Signaling
  5. Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
    Jonah Gordon, Gavin Lockard, Molly Monsour, Adam Alayli, Hassan Choudhary, Cesar V. Borlongan · 2022 · International Journal of Molecular Sciences
  6. Neuroprotective Effects of 3α-Acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide Against Dopamine-Induced Apoptosis in the Human Neuroblastoma SH-SY5Y Cell Line
    Uk Koo, Kung‐Woo Nam, Ahrom Ham, Dahyun Lyu, Bora Kim, Sung-Jin Lee, Kyeong Ho Kim, Ki-Bong Oh, Woongchon Mar, Jongheon Shin · 2011 · Neurochemical Research
  7. Neurotoxicology of dopamine: Victim or assailant?
    Meghan L. Bucher, Jocelyn Dicent, Gary Wright Miller · 2024 · NeuroToxicology
  8. Proceedings: Cell Therapies for Parkinson's Disease From Discovery to Clinic
    Rosa Canet-Aviles, Geoffrey P. Lomax, Ellen G. Feigal, Catherine A. Priest · 2014 · Stem Cells Translational Medicine
  9. Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy
    Robert L. Haining, Travis M. Jones, Aubrey Hernandez · 2016 · Neurochemical Research
  10. Regulating optoelectronics of carbon dots with redox-active dopamine
    Aradhana Panigrahi, Ranjan Kumar Behera, Leepsa Mishra, Priyanka Dubey, Soumi Dutta, Manas Kumar Sarangi · 2023 · Talanta Open
  11. Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generatedin vitro
    Masato Asanuma, Ikuko Miyazaki, Francisco J. Javier Diaz-Corrales, Masako Shimizu, Ken-ichi Tanaka, Norio Ogawa · 2005 · Neurological Research
  12. Differential vulnerability of locus coeruleus and dorsal raphe neurons to chronic methamphetamine-induced degeneration
    Yijuan Du, Sanghoon Choi, Alexander Pilski, Steven M. Graves · 2022 · Frontiers in Cellular Neuroscience
  13. Mitochondria and Parkinson's Disease
    David K. Simon, Charleen T. Chu, Russell Howard Swerdlow · 2011 · Parkinson s Disease
  14. VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1–linked Parkinson’s neurons
    Leonie M. Heger, Francesco Gubinelli, Andreas J. Huber, Aida Cardona‐Alberich, Matteo Rovere, Ulf Matti, Stephan A. Müller, Sankarshana R. Nagaraja, Lena Jaschkowitz, Martina Schifferer et al. · 2026 · Science Advances
  15. Comparison of automated and manual quantification methods for n euromelanin‐sensitive MRI in Parkinson's disease
    Nicholas A. Shaff, Erik Barry Erhardt, Stephanie R. Nitschke, Kayla R. Julio, Christopher J. Wertz, Andrei A. Vakhtin, Arvind Caprihan, Gerson Suarez‐Cedeño, Amanda Deligtisch, Sarah Pirio Richardson et al. · 2023 · Human Brain Mapping
  16. Arsenic and Oxidative Stress: An Overview
    Felor Zargari · 2021 · Springer eBooks
  17. Bioinformatic analysis for the identification of key candidate genes and pathways in the substantia nigra in Parkinson’s disease
    Hongbin Liu, Yongjun Huang, Jinyi Li · 2018 · Journal of Integrative Neuroscience
  18. Doença de Huntington
    Joana Gil‐Mohapel, Ana Cristina Rego · 2001 · Revista Neurociências
  19. In vitro neurotoxicity of salsolinol is attenuated by the presynaptic protein α-synuclein
    Phelippe do Carmo Gonçalves, Eduardo Coelho Cerqueira, Juliana R. Cortines, Theo Luiz Ferraz de Souza, Luciana Ferreira Romão, Cristian Follmer · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  20. Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats
    Diego Bustamante, Leonor Bustamante, Juan Segura‐Aguilar, Michel Goiny, Mario Herrera‐Marschitz · 2003 · Neurotoxicity Research
  21. Analysis of Quinone Reductase 2 Implication in Mechanism of Antiparkinsonian Action of Afobazole
    Кадников Илья Андреевич, Д. Н. Воронков, Михаил Владимирович Воронин, С. Б. Середенин · 2020 · Neurochemical Journal
  22. Neurodegeneration: The Size Takes It All
    Sandra Franco-Iborra, Céline Perier · 2015 · Current Biology
  23. Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington’s Disease
    Ricardo Leitão, Carla Guerreiro, Rita G. Nunes, Nilza Gonçalves, Giulia Galati, Madalena Rosário, Leonor Correia Guedes, Joaquim José Ferreira, Sofia Reimão · 2020 · Journal of Huntington s Disease
  24. Fading Blue: Exploring the Causes of Locus Coeruleus Damage Across the Lifespan
    Alessandro Galgani, Marco Scotto, Ugo Faraguna, Filippo Sean Giorgi · 2025 · Antioxidants
  25. Electropolymerized Congo Red Film based Sensor for Dopamine: A Voltammetric Study
    Chethan M. Kuskur, Kumara Swamy BE, Hanasavadi Parameshwarappa Jayadevappa, K. Shivakumar · 2018 · Insights in Analytical Electrochemistry
  26. Modulation of Iron Catalytic Activity to Dopamine Oxidation through Additional Iron Ligation
    Ming La, Chang-Dong Chen, He Li, Cheng‐Ye Yang · 2014 · International Journal of Electrochemical Science
  27. Molecular Markers of Dopamine Transport in Nigrostriatal Dopaminergic Neurons as an Index of Neurodegeneration and Neuroplasticity
    Eduard R. Mingazov, M. V. Ugryumov · 2019 · Neurochemical Journal
  28. Cytosolic non-vesicular dopamine accumulation as the predominant mechanism for developing non-DOPA responsive parkinsonism in late-stage Huntington disease
    Rafael Vincent M. Manalo · 2019 · Medical Hypotheses
  29. Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection
    Jacqueline A. Gleave, Peter D. Perri, Joanne E. Nash · 2014 · Frontiers in Biology
  30. OCT-based retinal biomarkers forecast central nervous system structural decline in Parkinson’s disease: A longitudinal multimodal study within the Persian Cohort
    Farzaneh Nikparast, Nooshin Akbari Sharak, Zohreh Ganji, Ali Shoeibi, Nasser Shoeibi, Hoda Zare · 2025 · Photodiagnosis and Photodynamic Therapy
  31. Distinctive characteristics of dopamine neuron release mechanisms: Insights into Parkinson’s Disease
    Emanuele Di Martino, Sarinah Maduro, Antonio Luchicchi, Micha M.M. Wilhelmus, Nicola Salvatore Orefice · 2026 · Biomedicine & Pharmacotherapy
  32. Melanins: functional properties and application possibilities in medical practice
    Olga Nikolaevna Usoltseva, Tatyana Vitalyevna Potupchik, A. A. Polyutova · 2024 · Farmaciya (Pharmacy)
  33. Postnatal hypoxia evokes persistent changes within the male rat’s dopaminergic system
    Michael John Decker, Karra A. Jones, Glenda L. Keating, David B. Rye · 2017 · Sleep And Breathing
  34. Einstein cosmological constant, the cell, and the intrinsic property of melanin to split and re-form the water molecule
    Arturo Solís Herrera · 2014 · MOJ Cell Science & Report
  35. Dopamine Homeostasis and Role of VMAT2 in Neurodegeneration
    Eugene V. Mosharov · 2022 · Springer eBooks
  36. Research Progress of Fluorescent Probes for Cysteine Targeting Cellular Organelles
    Fei-Ran Liu, Jing Jing, Xiaoling Zhang · 2023 · Youji huaxue
  37. Functionally Selective Dopamine D1 Receptor Endocytosis and Signaling by Catechol and Noncatechol Agonists
    Ashley N. Nilson, Daniel Eric Felsing, Pingyuan Wang, Manish Kumar Jain, Jia Zhou, John A. Allen · 2025 · Biochemistry
  38. Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease
    Cristina Viaggi, Daniela Di Camillo, Allison Wright Willis, L. Lozzi, Cristina Rocchi, Marta Capannolo, Gabriella Aloisi, Francesca Vaglini, Rita Maccarrone, Matteo Caleo et al. · 2013
  39. Regulation of DA Homeostasis and Role of VMAT2 in DA-Induced Neurodegeneration
    Eugene V. Mosharov · 2014 · Springer eBooks
  40. Differences Between Intact and Ovariectomized Hemiparkinsonian Rats in Response to L-DOPA, Melatonin, and L-DOPA/Melatonin Coadministration on Motor Behavior and Cytological Alterations
    Ana Luisa Gutiérrez-Valdez, Vianey Rodríguez-Lara, Verónica Anaya-Martı́nez, José Luis Ordóñez-Librado, Javier Sanchez-Betancourt, Enrique Montiel-Flores, Leonardo Reynoso Erazo, Rocío Tron-Alvarez, Patricia Aley-Medina, Jesús Espinosa-Villanueva et al. · 2018 · InTech eBooks
  41. Dopamine Homeostasis and Role of VMAT2 in Neurodegeneration
    Eugene V. Mosharov · 2021 · Springer eBooks
  42. Dopamine stabilized in ultra-nanoreservoirs for controlled delivery in parkinson’s disease
    Francisco Javier Padilla-Godínez, T. López, Evelyn Y. Calvillo-Muñoz, Mayra Angélica Alvarez Lemus, Juan Navarrete‐Bolaños, Omar Collazo-Navarrete, Obed‐Ricardo Lora‐Marin, María del Carmen Cárdenas‐Aguayo, Myrian Velasco, Magdalena Guerra‐Crespo · 2025 · Nanomedicine
  43. The DOPA scaffold: Tracing catechol chemistry from prebiotic earth to cognitive agency
    Amal Alachkar · 2025 · Progress in Biophysics and Molecular Biology
  44. DNA Damage Repair: A Crucial Link to Neurological Disorders
    Hui Yang, Yaqin Deng, Wansi Chen, Wei‐Guo Zhu, Xusheng Lu · 2026 · The FASEB Journal
  45. NIGROSTRIATAL DOPAMINE-NEURON FUNCTION FROM NEUROTROPHIC-LIKE PEPTIDE TREATMENT AND NEUROTROPHIC FACTOR DEPLETION
    O. Meagan Littrell · 2011 · UKnowledge (University of Kentucky)
  46. Einstein cosmological constant, the cell, and the intrinsic property of melanin to split and re-form the water molecule
    Arturo Solís Herrera, Paola Eugenia Solís Arias · 2014 · MOJ Cell Science & Report
  47. REVIEW ARTICLE Mechanisms of neurodegeneration in Huntington's disease
    Joana Gil‐Mohapel, Ana Cristina Rego · 2008
  48. Adrenergic regulation of cytoplasmic structures related to secretory processes in pig pinealocytes—an ultrastructural, quantitative study
    Barbara Przybylska‐Gornowicz, Bogdan Lewczuk, Natalia Ziółkowska, Magdalena Prusik · 2017 · Micron
  49. Role of Mitochondria and Oxidative Stress in Parkinson’s Disease
    Renato X. Santos, Sónia C. Correia, Susana Cardoso, Cristina Carvalho, Emanuel Candeias, Ana I. Plácido, Ana Isabel Duarte, Maria S. Santos, Paula Isabel Moreira · 2014 · CRC Press eBooks
  50. Dopamine Oxidation and Parkinson’s Disease
    Caitlyn W. Barrett, Meghan L. Bucher, Teresa G. Hastings · 2017 · Royal Society of Chemistry eBooks
  51. Parkinson's Disease
    Vaibhav Walia, Ashish Gakkhar, Munish Garg · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  52. Drosophila melanogaster mutant for the dopamine recycling pathway shows altered biological parameters and increased lifespan
    Martín M. Pérez, Fabiana Alejandra Rossi, Germán Sabio, Pablo Alejandro Bochicchio, María Celeste Leal, Luis Alberto Quesada-Allué, Alejandro Rabossi · 2021 · Entomologia Experimentalis et Applicata
  53. Characterization of Vesicular Monoamine Transporter 2 and its role in Parkinson's Disease Pathogenesis using Drosophila
    Antonio Joel Tito, Sheng Zhang · 2016 · Digital Commons-TMC (Texas Medical Center)
  54. CyDAP–A fluorescent probe for cytosolic dopamine detection
    Jing‐Yi Jeng, Sun Lee, Jia‐Chi Wang, Cheng-Yuan Lin, Chih-Ping Hung, Li‐An Chu, Hui-Yun Chang, Ann‐Shyn Chiang, Tzu‐Kang Sang · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Amelioration of L-DOPA-induced dyskinesia with vitamin D 3 in Parkinsonian mice model
    Adedamola Aminat Bayo-Olugbami, Abdulrazaq Bidemi Nafiu, Abdulbasit Amin, Olalekan Michael Ogundele, Charles C. Lee, Bamidele Victor Owoyele · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Development of Viral Tools for CNS Gene Transfer: Adeno-Associated Viral Vectors in Gene Therapy of Parkinson's Disease
    Shevtsova, Zinayida · 2006 · eDiss (Georg-August-Universität Göttingen)
  57. Neuropharmacology and toxicology of novel amphetamine-type stimulants
    Bjørnar den Hollander · 2015
  58. A D. melanogaster parkin mutant larval model of Parkinson's Disease
    Amanda Vincent · 2013 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  59. Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de Huntington
    Paola Paoletti Rubia · 2010 · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
  60. THE NON-HUMAN PRIMATE AS A MODEL OF HUMAN PARKINSONISM
    Alison L. McCormack · 2006 · Figshare
  61. Deuterium-L-DOPA: a Novel Means to Improve Treatment of Parkinson's Disease
    Torun Malmlöf · 2012 · Figshare
  62. Convergence of Multiple Hits that Could Underlie Parkinson‘s Disease
    Eugene V. Mosharov, David L. Sulzer · 2009 · Future Neurology
  63. Review Autophagy in neurons: a review
    Kristin E. Larsen, David L. Sulzer · 2002
  64. MRI assessment of brain iron content in methamphetamine users
    Yosef A. Berlow · 2014
  65. Inhibition of monoamine oxidase B by selec- tive 7-substituted coumarin derivatives
    Bennie Repsold, Jacobus Petrus Petzer, Jacobus J. Bergh, Sarel F. Malan · 2008
  66. INVESTIGATING EFFECTS OF THE ANTIBIOTIC CIPROFLOXACIN ON THE DOPAMINERGIC SH-SY5Y CELL LINE
    Jeffreys N Johnson · 2021 · Scholarworks (University of Massachusetts Amherst)
  67. Dopamine and dopamine-quinones toxicity in Parkinson's disease: cellular models revealing a possible role for superoxide dismutases
    Rekha Cappellini · 2013 · Padua@research (University of Padova)
  68. MECHANISMS OF VESICULAR MONOAMINE TRANSPORTER-2 DEGRADATION
    Erin K. Stachowski · 2017 · D-Scholarship@Pitt (University of Pittsburgh)
  69. A model of delta frequency neuronal network activity and theta-gamma interactions in rat sensorimotor cortex in vitro
    Swetha Sri Kalyanapu · 2017 · Aston Publications Explorer (Aston University)
  70. Membrane partitioning by Flotillin-1 facilitates amphetamine-induced dopamine transporter activity
    Wendy M. Fong · 2017
  71. Neurodegeneration induced by ß-synuclein in the context of the neurotransmitter dopamine
    Anupam Raina · 2019
  72. Systems Genetics and Systems Biology Analysis of Paraquat Effects in BXD Recombinant Inbred Mice
    Carolina Torres-Rojas · 2020
  73. Mecanismes de toxicitat de la dopamina en cèl·lules de neuroblastoma humà SH-SY5Y
    Pol Giménez Xavier · 2008 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  74. Animal Models of Parkinson's Disease
    Hardy J. Rideout, Leonidas Stefanis · 2011 · Royal Society of Chemistry eBooks
  75. Calcium Homeostasis in Dopaminergic Neurons
    Anika K. Frank, Siham Boumhaouad, Stavros Fanourakis, David L. Sulzer, Eugene V. Mosharov · 2024 · Oxford University Press eBooks
  76. The current state of research on the pharmacological properties of melanins and the prospects for their use in medicine
    А. М. Сампиев, Batchaeva A.Kh., B.N. Zhitar, Tatyana Vitalyevna Potupchik · 2024 · Farmaciya (Pharmacy)
  77. Neuromelanin: Bridging catecholamine metabolism and neurodegeneration in Parkinson's disease
    Marta González-Sepúlveda, Joana M. Cladera-Sastre, Miquel Vila · 2025 · Handbook of behavioral neuroscience
  78. Electrophysiological characterization of neuronal diversity in the substantia nigra pars reticulata in control and parkinsonian mice
    Lorena Delgado-Zabalza · 2020
  79. Study of neuronal networks and mechanisms implicated in locomotor reactivity and Parkinson's disease pathogenesis in the Drosophila model
    Jun Sun · 2018 · theses.fr (ABES)
  80. Apport de l'IRM multimodale pour le diagnostic différentiel des syndromes parkinsoniens
    Lydia Chougar · 2022
  81. Multi-Step Amperometry for Detecting Dopamine Using Boron-Doped Diamond Microelectrodes in the Striatum of the Mouse Brain
    Rina Okochi, Genki Ogata, Masayo Fujita, Lea Jiang, Soichiro Ide, Kazuto Kobayashi, Kazutaka Ikeda, Yasuaki Einaga · 2026 · ACS Sensors
  82. Structural and functional insights into aromatic amino acid decarboxylase deficiency variants producing an α-synuclein-targeting L-Dopa–pyridoxal 5′-phosphate cyclic adduct
    Philipp Trolese, Giovanni Bisello, Cristian Andres Carmona‐Carmona, Giulia Spagnoli, Alberto Benetollo, Dorianna Sandonà, Laura Acquasaliente, Patrizia Polverino de Laureto, Mariarita Bertoldi · 2026 · International Journal of Biological Macromolecules